Holen Sie sich die Stockscreener-App
0.1976
13.35%
-0.0305
Schlusskurs vom Vortag:
$0.2281
Offen:
$0.2263
24-Stunden-Volumen:
2.88M
Relative Volume:
2.19
Marktkapitalisierung:
$12.27M
Einnahmen:
$69.49M
Nettoeinkommen (Verlust:
$-21.13M
KGV:
-0.3045
EPS:
-0.649
Netto-Cashflow:
$-14.46M
1W Leistung:
-27.04%
1M Leistung:
-35.60%
6M Leistung:
-55.67%
1J Leistung:
-59.92%
1-Tages-Spanne:
$0.196
$0.2263
1-Wochen-Bereich:
$0.1952
$0.2799
52-Wochen-Spanne:
$0.1952
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
Firmenname
Cosmos Health Inc
Sektor
Branche
Telefon
312-536-3102
Adresse
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.1977 | 14.16M | 69.49M | -21.13M | -14.46M | -0.649 |
MCK
Mckesson Corp
|
793.97 | 95.01B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
283.88 | 54.72B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
222.81 | 50.66B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
80.09 | 8.98B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.37 | 1.19B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc Aktie (COSM) Neueste Nachrichten
Cosmos Health Secures Additional 180-Day Nasdaq Extension To Regain Bid Price Compliance - TradingView
Cosmos Health gets Nasdaq extension to regain $1 minimum bid price - Investing.com
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance - lincolnjournal.com
Cosmos Health CEO addresses shareholders amid stock decline - Investing.com UK
Cosmos Health targets $200M revenue by 2029, driven by U.S. expansion - scanx.trade
$20 Million in Liquid Assets Support Rapid Growth Including Acquisitions, Bio Pharma Production and Nanotechnology Initiatives for Diversified Global Heath Leader Cosmos Health, Inc. (Nasdaq: COSM) - Barchart.com
Cosmos Health (COSM) Secures Manufacturing Deal with Verisfield S.A. - GuruFocus
Cosmos Health subsidiary secures manufacturing deal - Investing.com
Cosmos Health Inc. - Via Ritzau
Cosmos Health CEO addresses shareholders amid stock decline By Investing.com - Investing.com Canada
Cosmos Health CEO Issues Letter to Shareholders: Building - GlobeNewswire
Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway - Yahoo Finance
Cosmos Health subsidiary secures 5-year manufacturing deal - Investing.com UK
Cosmos Health (COSM) Launches New Capsule Production and Signs C - GuruFocus
Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com Canada
Cosmos Health Inc. Subsidiary Cana Laboratories Inaugurates New Capsule Production Line and Secures Contract with Provident Pharmaceuticals - Quiver Quantitative
Factory upgrade backs 385,000-dose antidepressant deal contract - Stock Titan
Cosmos Health (COSM) Expands Innovation with Patent Acquisition - GuruFocus
Cosmos Health subsidiary acquires nanotechnology patent By Investing.com - Investing.com Australia
Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives - The Manila Times
Cosmos Health subsidiary acquires nanotechnology patent - Investing.com
Cosmos Health Inc. Subsidiary Cana Laboratories Acquires International Patent to Enhance Nanotechnology Investment Initiatives - Quiver Quantitative
Cosmos Health Completes Acquisition of Strategic - GlobeNewswire
New nanotech patent backs Cosmos Health’s next-gen pharma plans - Stock Titan
Andreas Bovopoulos holds 4.32M Cosmos Health (COSM) shares — Schedule 13G/A - Stock Titan
Cosmos Health Inc.: Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories - FinanzNachrichten.de
Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories - The Manila Times
New Oliv18 capsule packs 11 tsp of olive oil for heart support - Stock Titan
Key facts: Cosmos Health may monetize ~$15M assets; lists 96 products EU - TradingView
Cosmos Health Inc. (NASDAQ: COSM) $200M shelf; discloses crypto treasury strategy - Stock Titan
Cosmos Health expands Sky Premium Life to all 27 EU states - Investing.com UK
Cosmos Health launches Fort18 men’s wellness supplement in U.S. - Investing.com
$65.3 Million Revenue in 2025 Followed by Q1 2026 Record of $17.9 Million with Momentum Continuing in Q2 for Diversified Global Heath Leader Cosmos Health Inc. (Nasdaq: COSM) - Barchart.com
Cosmos Health expands Sky Premium Life to all 27 EU states By Investing.com - Investing.com South Africa
Vitamins brand Sky Premium Life goes on sale in all 27 EU countries - Stock Titan
Cosmos Health (COSM) to Explore Monetization of Non-Core Assets - GuruFocus
Cosmos Health explores sale of non-core assets worth $20M By Investing.com - Investing.com India
Cosmos Health explores sale of non-core assets worth $20M - Investing.com Nigeria
Cosmos Health Identifies Approximately $20 Million in - GlobeNewswire
Cosmos Health Inc. Identifies $20 Million in Non-Core Assets for Potential Monetization - Moomoo
Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value - The Globe and Mail
Cosmos Health Bets the Farm—Literally—on a $20 Million Revival Plan - BriefGlance
Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029 - WBOC TV
Cosmos Health (NASDAQ: COSM) outlines 2026 proxy, 10M-share equity plan and Series B preferred - Stock Titan
Cosmos Health reports balance sheet improvements, EIB talks By Investing.com - Investing.com South Africa
Cosmos Health reports balance sheet improvements, EIB talks - Investing.com
Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent S - The Manila Times
Cosmos Health trims $4.5M debt, weighs €25M EIB deal, drops 38% warrants - Stock Titan
Cosmos Health Provides Balance Sheet Update: Highlights - GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Cosmos Health extends C-Scrub brand into veterinary market By Investing.com - Investing.com South Africa
Finanzdaten der Cosmos Health Inc-Aktie (COSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cosmos Health Inc-Aktie (COSM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
| Siokas Grigorios | Chief Executive Officer |
Jan 08 '26 |
Buy |
0.52 |
156,190 |
81,000 |
7,131,794 |
| Siokas Grigorios | Chief Executive Officer |
Jan 07 '26 |
Buy |
0.52 |
124,880 |
65,000 |
6,975,604 |
| Siokas Grigorios | Chief Executive Officer |
Jan 06 '26 |
Buy |
0.54 |
133,953 |
72,000 |
6,850,724 |
| Siokas Grigorios | Chief Executive Officer |
Dec 19 '25 |
Buy |
0.49 |
88,314 |
43,000 |
6,716,771 |
| Siokas Grigorios | Chief Executive Officer |
Dec 15 '25 |
Buy |
0.42 |
168,472 |
70,000 |
6,628,457 |
14.34%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):